Recombinant surfactant protein D

DB18438InvestigationalProtein Based Therapies

Recombinant surfactant protein D: Overview.

Mechanism: Pharmacologically active on Angiotensin-converting enzyme 2 and Spike glycoprotein
Curator reviewed
Also known as: Recombinant surfactant SP-D · rfhSP-D

Resolves to

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Recombinant surfactant protein D, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.